Evaluating the developmental toxicity of trypanocidal nitroaromatic compounds on zebrafish

Area of Science:

• Drug discovery and toxicology
• Parasitology and tropical diseases
• Developmental biology

Background:

• Current treatments for African and American trypanosomiasis are inadequate.
• There is an urgent need for novel, cost-effective therapeutic agents.
• Vaccine development for trypanosomiasis is not on the immediate horizon.

Purpose of the Study:

• To introduce a novel in vivo screening method for assessing compound developmental toxicity.
• To facilitate rapid drug discovery for trypanosomiasis.
• To validate a new screening approach using established trypanocidal drugs.

Main Methods:

• Utilized zebrafish (Danio rerio) embryos as a model system.
• Developed a high-throughput screening assay for developmental toxicity.
• Validated the assay with known nitroaromatic prodrugs, including nifurtimox and benznidazole.

Main Results:

• Demonstrated the utility of zebrafish embryos for rapid developmental toxicity assessment.
• Successfully validated the screening approach with existing trypanocidal compounds.
• Established a foundation for high-throughput screening in antiparasitic drug discovery.

Conclusions:

• Zebrafish embryo screening is a viable, rapid method for evaluating drug developmental toxicity.
• This approach can significantly accelerate the drug discovery pipeline for neglected tropical diseases like trypanosomiasis.
• The validated method aids in identifying safer and more effective trypanocidal drug candidates.